Právní předpis byl sestaven k datu 22.05.2026.
Zobrazené znění právního předpisu je účinné od 17.12.2016.
Sdělení o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2017
390/2016 Sb.
390
XXXXXXX
Xxxxxxxxxxxx zdravotnictví
ze xxx 28. xxxxxxxxx 2016
o xxxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx pravidelná, xxxxxxxx x mimořádná xxxxxxxx pro xxx 2017
Xxxxxxxxxxxx xxxxxxxxxxxxx xxxxx §80 xxxx. 1 xxxx. e) zákona x. 258/2000 Xx., x xxxxxxx veřejného xxxxxx a x xxxxx některých souvisejících xxxxxx, ve xxxxx xxxxxxxxxx xxxxxxxx, xxxxxxx xx xxxxxxx xxxxxxxxxx Xxxxxxx xxxxxxxxxx xxxxxx xxxxxxxxx xxxxxxx očkovacích xxxxx xxx pravidelná, xxxxxxxx x xxxxxxxxx xxxxxxxx xxx xxx 2017:
1. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxxx xxxxxxxx
1x) xxxxxxxxxxx xxxxxxxx látka xxxxx xxxxxxx, dávivému xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx obrně (xxxxxxxxxxxx xxxxx), xxxxxx xxxxxxxxxx X, xxxxxxx xxxxxxxxx Haemophilus influenzae xxx b (XXxXXxxXXXXXX):
Xxxxxxxxxxx xxxxxxxxxx1 xx xxxx xxx 30 mezinárodních xxxxxxxx (IU)
Tetani xxxxxxxxxx1 xx xxxx xxx 40 xxxxxxxxxxxxx jednotek (XX)
Xxxxxxxx Xxxxxxxxxx pertussis:
Pertussis xxxxxxxxxx1 25 xxxxxxxxxx
Xxxxxxxxxxxxxxxx xxxxxxxxxxxx1 25 mikrogramů
Pertactinum1 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X2,3 10 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxx (inaktivovaný)
typus 1 (xxxx Xxxxxxx)4 40 X jednotek xxxxxxxx
xxxxx 2 (xxxx XXX-1)4 8 D xxxxxxxx antigenu
typus 3 (xxxx Xxxxxxx)4 32 X xxxxxxxx xxxxxxxx
Xxxxxxxxxxx xxxxxxxxxx xxxxx b xxxxxxxxxxxxxxx 10 xxxxxxxxxx
(xxxxxxxxxxxxxxxxxxx xxxxxxxx)3
xxxxxxxxx xxx tetani xxxxxxxxxx xxxx xxxxxx xxxxxxxxx xxxxxxxxx 25 xxxxxxxxxx
XXXX
1xx) xxxxxxxxxxx očkovací xxxxx xxxxx xxxxxxx, xxxxxxxx kašli (acelulární xxxxx), tetanu, dětské xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx), xxxxxx xxxxxxxxxx X, xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx typ x (DTaPHibVHBIPV)
Diphtheriae xxxxxxxxxx xx méně xxx 20 mezinárodních xxxxxxxx (XX)2
Xxxxxx xxxxxxxxxx xx xxxx xxx 40 xxxxxxxxxxxxx xxxxxxxx (IU)2
Antigeny Xxxxxxxxxx xxxxxxxxx
Xxxxxxxxx xxxxxxxxxx 25 mikrogramů
Haemagglutinum filamentosum 25 xxxxxxxxxx
Xxxxx Xxxxxxxxxxxxxxx (xxxxxxxxxxxx)3
xxxxx 1 (Mahoney) 40 X xxxxxxxx xxxxxxxx4
xxxxx 2 (XXX-1) 8 X xxxxxxxx xxxxxxxx4
xxxxx 3 (Xxxxxxx) 32 D jednotek xxxxxxxx4
Xxxxxxxxx xxxxxxxxx xxxxxxxxxx X5 10 mikrogramů
Haemophilus xxxxxxxxxx xxxx b xxxxxxxxxxxxxxx 12 xxxxxxxxxx
(Xxxxxxxxxxxxxxxxxxx xxxxxxxx)
xxxxxxxxx xxx tetani xxxxxxxxxx 22-36 mikrogramů
1b) xxxxxxxx xxxxx xxxxx xxxxxxx, dávivému kašli (xxxxxxxxxx forma), tetanu (XXxX):
Xxxxxxxxxxx anatoxinum ³ 30 xxxxxxxxxxxxx jednotek
Tetani xxxxxxxxxx ³ 40 xxxxxxxxxxxxx xxxxxxxx
Xxxxxxxxx xxxxxxxxxx (XX) 25 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX) 25 xxxxxxxxxx
Xxxxxxxxxxx (69xX) 8 xxxxxxxxxx
XXXX
1xx) Očkovací xxxxx xxxxx xxxxxxx, xxxxxx a xxxxxxxx xxxxx (xxxxxxxxxx)
|
1 xxxxx (0,5 xx) obsahuje: Xxxxxxxxxxx xxxxxxxxxx |
Xxxxxxxxx 2 XX* (2 Xx) |
|
Xxxxxx xxxxxxxxxx |
Xxxxxxxxx 20 XX* (5 Xx) |
|
Xxxxxxxxx xxxxxxxx |
|
|
Xxxxxxxxx xxxxxxxxxx |
2,5 xxxxxxxxxx |
|
Xxxxxxxxxxxxxx xxxxxxxxxxxx |
5 xxxxxxxxxx |
|
Xxxxxxxxxxx |
3 xxxxxxxxxx |
|
Xxxxxxxx, typi 2 xx 3 |
5 xxxxxxxxxx |
|
Xxxxxxxxxxx na xxxxxxxxxxx xxxxxxx |
1,5 mg (0,33 xx hliníku) |
NEBO
1bb) Xxxxxxxx xxxxx xxxxx záškrtu, xxxxxx a xxxxxxxx xxxxx (xxxxxxxxxx xxxxxxxxxx) xx xxxxxxxx xxxxxxx xxxxxxxx
Xxxxxxxxxxx xxxxxxxxxx1 xx xxxx xxx 2 xxxxxxxxxxx xxxxxxxx (XX) (2,5 Xx)
Xxxxxx xxxxxxxxxx1 xx xxxx xxx 20 xxxxxxxxxxxxx jednotek (XX) (5 Xx)
Xxxxxxxxxxx xxxxxxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxxx1 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx1 8 mikrogramů
Pertussis xxxxxxxxx externae xxxxxxxxx1 2,5 xxxxxxxxxx
1 xxxxxxxxxxx xx xxxxxxxxxxx hydroxid xxxxxxx (AI(OH)3) 0,3 xxxxxxxxx XX3+
x xxxxxxxxxxx xxxxxxx (XXX04) 0,2 xxxxxxxxx AI3+
1c) xxxxxxxx xxxxx xxxxx záškrtu, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxxx xxxxxxxxx Xxxxxxxxx xxxxxxxxxx x (XXxXXxx):
|
Xxxxxxxxxxx xxxxxxxxxx |
xxx. 30 xxxxxxxxxxxxx jednotek |
|
Tetani xxxxxxxxxx |
xxx. 40 xxxxxxxxxxxxx xxxxxxxx |
|
Xxxxxxxxx xxxxxxxxxx (XX) |
25 xxxxxxxxxx |
|
Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx |
(XXX) 25 xxxxxxxxxx |
|
Xxxxxxxxxxx (69kD) |
8 xxxxxxxxxx |
|
Xxxxxxxxxxx influenzae X |
10 xxxxxxxxxx |
|
xxx xxxxxxxxx xxxxxxxx |
20-40 xxxxxxxxxx |
1x) xxxxxxxx xxxxx xxxxx xxxxxxx vyvolaným Xxxxxxxxxxx xxxxxxxxxx xxx x:
1 xxxxx xxxxxxxxxxxxx xxxxxxx xxxxxxxx: Xxxxxxxxxxxxxxx Xxx purificatum (10 xxxxxxxxxx) xxx Xxxxxxxxx xxxxxxxx (xxxxxxxxx 25 xxxxxxxxxx).
1x) očkovací látka xxxxx xxxxxx:
Xxxxxx xxxxxxxxxx … xxx. 40 xxxxxxxxxxxxx jednotek
1f) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xx 16 let x xxxx:
|
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X |
20 xxxxxxxxxx |
1x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X x xxxxxx xxxxxxx:
|
Xxxxxxxxx tegiminis xxxxxxxxxxx X |
10 xxxxxxxxxx |
1x) xxxxxxxx xxxxx xxxxx xxxxxxxxxx, příušnicím x xxxxxxxxx:
Xxxxxxxxxxx xxxxx attenuatum (Xxxxxxx) min. 103,0 xxxxxxxx xxxxx pro xxxxxxxx xxxxxxx50 Xxxxxxxxxxx xxxxx xxxxxxxxxx (RIT 4385) xxx. 103,7 xxxxxxxx dávka xxx xxxxxxxx xxxxxxx50 Xxxxxxxx xxxxx xxxxxxxxxx (Xxxxxx XX 27/3) min. 103,0 infekční xxxxx xxx xxxxxxxx xxxxxxx50
1xx) xxxxxxxx látka xxxxx xxxxxx xxxxxxxx xxxxx x xxxxxxxxxxxx xxxxx:
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx typus 1 (Mahoney) … 40 xxxxxxxxxxx X xxxxxxxx*
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 2 (XXX-1) … 8 xxxxxxxxxxx X xxxxxxxx*
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx typus 3 (Xxxxxxx) … 32 xxxxxxxxxxx D xxxxxxxx*
* xxxx xxxxxxxx xxxxxxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxx xxxxxx xxxxxxxxxxxxx metody.
1i) xxxxxxxx xxxxx xxxxx xxxxxxx vyvolaným Xxxxxxxxxxxxx xxxxxxxxxx v xxxxxxxxxxxxxxx xxxxxxx:
Xxxxxxxxxxxxxxx Xxxxxxxxxxxx xxxxxxxxxx xxxxx:
1, 2, 3, 4, 5, 6X, 7X, 8, 9X, 9X, 10X, 11X, 12X, 14, 15X, 17X,
18X, 19X, 19F, 20, 22X, 23X, 33X … 25 xxxxxxxxxx x každého xxxxxxxx
1x) xxxxxxxx látka xxxxxxxxxxx xxxxx xxxxxxxxxxxxx xxxxxxxx:
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 1
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 3
Xxxxxxxxxxxxx polysaccharidum xxxxxxxxx 4
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 5
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6X
Xxxxxxxxxxxxx polysaccharidum sérotypus 6X
Xxxxxxxxxxxxx polysaccharidum xxxxxxxxx 7X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 9X
Xxxxxxxxxxxxx polysaccharidum xxxxxxxxx 14
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 18X
Xxxxxxxxxxxxx polysaccharidum xxxxxxxxx 19X
Xxxxxxxxxxxxx polysaccharidum xxxxxxxxx 19X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 23X
1x) xxxxxxxx xxxxx xxxxx xxxxxxx, dávivému xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (inaktivovaná forma):
|
Xxxxxxxxxxx xxxxxxxxxx |
xx xxxx xxx 2 mezinárodní xxxxxxxx |
|
Xxxxxx xxxxxxxxxx |
xx méně xxx 20 xxxxxxxxxxxxx xxxxxxxx |
|
Xxxxxxxxx xxxxxxxx: |
|
|
Xxxxxxxxx xxxxxxxxxx |
8 xxxxxxxxxx |
|
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx |
8 xxxxxxxxxx |
|
Xxxxxxxxx |
2,5 xxxxxxxxxx |
|
Xxxxx poliomyelitidis xxxxxxxxxxx: |
|
|
xxxxx 1 (kmen Xxxxxxx) |
40 D xxxxxxxx xxxxxxxx |
|
xxxxx 2 (xxxx XXX-1) |
8 X jednotek xxxxxxxx |
|
xxxxx 3 (xxxx Xxxxxxx) |
2 X jednotek xxxxxxxx |
XXXX
1x) xxxxxxxx látka xxxxx xxxxxxx, xxxxxxxx xxxxx (acelulární forma), xxxxxx, dětské xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):
|
Xxxxxxxxxx xxxxxx |
xxxx xxxx xxxxx 2 xxxxxxxxxxx jednotky (2 Xx) |
|
Xxxxxxxxx xxxxxx |
xxxx xxxx xxxxx 20 xxxxxxxxxxxxx jednotek (5 Xx) |
|
Xxxxxxxxx antigeny: |
|
|
Xxxxxxxxx xxxxxx |
2,5 mikrogramu |
|
Xxxxxxxxxxxx xxxxxxxxxxxx |
5 xxxxxxxxxx |
|
&xxxx;&xxxx; Xxxxxxx xxxx 2+3 |
5 mikrogramů |
|
Xxxxxxxxx |
3 xxxxxxxxxx |
|
Xxxxx poliomyelitis xxxx 1 (xxxxxxxxxxxx) |
40 xxxxxxxxxxx D jednotek |
|
Virus xxxxxxxxxxxxx xxxx 2 (xxxxxxxxxxxx) |
8 antigenních X xxxxxxxx |
|
Xxxxx xxxxxxxxxxxxx xxxx 3 (xxxxxxxxxxxx) |
32 xxxxxxxxxxx X xxxxxxxx |
1x) očkovací xxxxx xxxxx xxxxxxxxxxx (XXX xxxxxxx)
1x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx B xxx xxxxx xxxxxxxx do xxxxxxxxxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx B biosyntheticum 20 xxxxxxxxxx; xxxxxxxx XX04X xxxxxxxxxx 3-X-xxxxxx-4-xxxxxxxxxxxx-xxxxx X (XXX) 50 xxxxxxxxxx x 1 xxxxx
2. Xxxxxxxxx xxxxxxx xxxxxxxxxx látek xxx xxxxxxxx xxxxxxxx
2x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X ve xxxxxxx xxx dospělé:
|
Antigenum xxxxxxxxx xxxxxxxxxxx X |
20 xxxxxxxxxx |
2x) xxxxxxxx xxxxx xxxxx xxxxxxxxx
2x) očkovací xxxxx xxxxx virové xxxxxxxxxx A ve xxxxxxx xxx dospělé:
Hepatitis X xxxxx xxxxxxxxxxx
3. Xxxxxxxxx složení očkovacích xxxxx pro xxxxxxxxx xxxxxxxx
3x) očkovací xxxxx xxxxx virové xxxxxxxxxx X xx formuli xxx dospělé:
Hepatitis X xxxxx xxxxxxxxxxx
3x) očkovací xxxxx proti xxxxxx xxxxxxxxxx A ve xxxxxxx pro xxxx:
Xxxxx xxxxxxxxx X xxxxxxxxxxx
X xxxx 2017 s xxxxxxx na xxxxxxxxxx xxxxxxxxxx xxxxxxxx č. 537/2006 Sb., x xxxxxxxx xxxxx xxxxxxxxx xxxxxxx, ve xxxxx xxxxxxxxxx xxxxxxxx, xxxxx vyloučit xxxxxxxxx xxxxxx xxxxxxxxxxx složení xxxxxxxxxx xxxxx pro xxxxxxxxxx xxxxxxxx xxxxxxxxxxxx xxxxxx xxxxxxxxxxx xxxxxxx xxxxxx očkovacích látek xx Xxxxxx xxxxxx.
Xxxxxxx:
XXXx. Xxxxxxx, MBA, x. x.
Informace
Právní předpis x. 390/2016 Sb. nabyl xxxxxxxxx xxxx 17.12.2016.
Ke xxx uzávěrky xxxxxx xxxxxxx xxxxx xxxxx xx doplňován.
Znění xxxxxxxxxxxx xxxxxxxx norem xxxxxx xxxxxxxx předpisů x xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx se xxxx xxxxxx derogační xxxxx xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.